Data are mean SEM, n = 8/group
If lifestyle measures and over-the-counter laxatives are insufficient, prescription options or specialist referral may be warranted
Gensous, N., Franceschi, C., Santoro, A., Milazzo, M., Gar- agnani, P
This research specifically focused on people with type 2 diabetes, so more research is needed in other groups, and the results should not be generalized
Wegovy (semaglutide) is an injectable medication that is used with a reduced-calorie diet and increased exercise to help manage chronic weight in adults who are: Obese (body mass index = 30 kg/m2) OR Overweight (body mass index = 27 kg/m2) with at least one weight-related condition (e.g., high blood pressure, diabetes, high cholesterol) Wegovy is classified as a glucagon-like peptide-1 (GLP-1) receptor agonist